Company Reports (Pharma & Healthcare)


Company Reports (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Company Reports in the Pharma and healthcare gives a comprehensive coverage on a various company's activities in the medical field.

In the Pharma and Healthcare company reports, it gives information on various companies in healthcare industry.

The Company reports, gives information on these topics.

  • Current developmental pipeline and latest updates of pharmaceutical companies.
  • Business description
  • Key information and facts
  • Major projects accomplished
  • Company’s location and their subsidiaries
  • Market share analysis
  • Research and development
  • Competitor’s in Pharma and healthcare industry
  • Prospects of the company
  • Shareholders and latest news on company products.

List of top 12 fortune 500 Pharma companies worldwide given by CNN Money are Pfizer, Johnson & Johnson, Merck, Abbot Laboratories, Eli Lilly, Bristol-Myers Squibb, Amgen, Gilead Sciences, Mylan, Allergan, Biogen Idec, and Celgene. 

Publication Single User License (PDF) Price
Cigna-HealthSpring : Company Profile and SWOT Analysis

Cigna-HealthSpring : Company Profile and SWOT Analysis

Date Published: Jan 20 2015

This report is a crucial resource for industry executives and anyone looking to access key information about "Cigna-HealthSpring "

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

$125.00
ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Advanced BioMedical Technologies, Inc. (ABMT) - Financial and Strategic SWOT Analysis Review

Advanced BioMedical Technologies, Inc. (ABMT) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis Review

ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Enanta Pharmaceuticals, Inc. (ENTA) - Financial and Strategic SWOT Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic SWOT Analysis Review

Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Marksans Pharma Limited (MARKSANS) - Financial and Strategic SWOT Analysis Review

Marksans Pharma Limited (MARKSANS) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Accentia Technologies Ltd (531897) - Financial and Strategic SWOT Analysis Review

Accentia Technologies Ltd (531897) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Lansen Pharmaceutical Holdings Ltd. (503) - Financial and Strategic SWOT Analysis Review

Lansen Pharmaceutical Holdings Ltd. (503) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic SWOT Analysis Review

Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Brainsway Ltd. (BRIN) - Financial and Strategic SWOT Analysis Review

Brainsway Ltd. (BRIN) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic SWOT Analysis Review

Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic SWOT Analysis Review

Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
ValiRx Plc (VAL) - Financial and Strategic SWOT Analysis Review

ValiRx Plc (VAL) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
AlumiFuel Power Corporation (AFPW) - Financial and Strategic SWOT Analysis Review

AlumiFuel Power Corporation (AFPW) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
The Westaim Corporation (WED) - Financial and Strategic SWOT Analysis Review

The Westaim Corporation (WED) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

The Westaim Corporation (Westaim) is a financial service provider. The organization provides long-term capital to businesses operating primarily within the global financial services industry. It invests through acquisitions, joint ventures and other arrangements. The organization invests in various business sectors and partners with other companies. It is a subsidiary of JEVCO Insurance Company, a property and casualty insurance company. Westaim is headquartered in Toronto, Ontario, Canada.

$300.00
Towa Pharmaceutical Co., Ltd. (4553) - Financial and Strategic SWOT Analysis Review

Towa Pharmaceutical Co., Ltd. (4553) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
DBV Technologies S.A. (DBV) - Financial and Strategic SWOT Analysis Review

DBV Technologies S.A. (DBV) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Hualan Biological Engineering, Inc. (002007) - Financial and Strategic SWOT Analysis Review

Hualan Biological Engineering, Inc. (002007) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data